kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance KRAS | OriGene Technologies Inc.
KRAS OriGene Technologies Inc. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt Tanaka 2025 Cancer Science Wiley Online Library
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



